Matthew Worrall Director, Corporate Communications and Public Affairs, Ferring +447442 271811 [email protected] Tomas de Wouters CEO, PharmaBiome +41 44 552 03 04 [email protected] ...

Turners Hill CofE Primary School 94 41 101.8 St Joseph's Catholic Primary School, Haywards Heath 93 47 101.7 Ferring CofE Primary School 90 31 101.7 Blackthorns Community Primary School, Lindfield ...

Contacts. For more information: Bhavin Vaid Head of Corporate Communications +41 58 301 0952 (direct) +41 79 191 0632 (mobile) [email protected] Victoria Buenemann Communications & Business ...

Ferring Pharmaceuticals has acquired exclusive licensing rights to the Phase III radicular leg pain candidate SI-6603 (condoliase) from Seikagaku, the companies said today. Seikagaku said the deal ...

Ferring Pharmaceuticals and Posterity Health, a male fertility center of excellence, have partnered to launch a male fertility program. The two organizations announced the program’s debut on Thursday ...

Ferring Pharmaceuticals’ chief operating officer and president of its executive board, Michel Pettigrew, announced that he plans to retire Dec. 31. Chief Science Officer Per Falk, M.D., Ph.D ...

RELATED: Ferring's C. difficile drug overcomes skepticism to secure FDA committee nod C. diff. is a superbug that resists antibiotics and other medications. The disorder causes roughly 500,000 ...

The clear-eyed assessment of the company’s priorities set the record straight as to why the Ferring Research Institute, one of the company’s three main R&D hubs, closed after 27 years.

Ferring Pharmaceuticals is setting the record straight on fertility issues. Because infertility is often branded largely as a women’s issue, many men may be unaware of their own possible role in ...